Vontobel Holding Ltd. Lowers Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Vontobel Holding Ltd. trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 92.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 107,558 shares of the healthcare conglomerate's stock after selling 1,251,300 shares during the period. Vontobel Holding Ltd.'s holdings in UnitedHealth Group were worth $54,409,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the fourth quarter valued at $30,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group in the 3rd quarter worth approximately $37,000. Friedenthal Financial bought a new position in UnitedHealth Group during the third quarter valued at approximately $51,000. DecisionPoint Financial LLC boosted its stake in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock valued at $52,000 after purchasing an additional 62 shares in the last quarter. Finally, Highline Wealth Partners LLC bought a new stake in UnitedHealth Group in the third quarter worth $55,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent research reports. Truist Financial lowered their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Stephens raised their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a report on Thursday, December 5th. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Deutsche Bank Aktiengesellschaft lifted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. Finally, Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a report on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH traded down $7.70 on Monday, reaching $523.48. The company's stock had a trading volume of 3,703,659 shares, compared to its average volume of 4,348,924. The stock's 50 day simple moving average is $523.11 and its two-hundred day simple moving average is $563.00. The stock has a market capitalization of $481.75 billion, a P/E ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the business posted $5.83 earnings per share. The company's revenue was up 6.8% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. 0.33% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.